Skip to content
← Full study record

NCT04505553 · OUTCOME

Change in Severity of Pain, Fatigue, Nausea, and Anxiety From Baseline to 3 Months

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer · Source last updated 2026-01-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
units on a scale
Interval / dispersion
Standard Deviation
Time frame
3 months

What was measured

Measured by patient-reported National Cancer Institute \[NCI\] Patient Reported Outcomes \[PRO\]-CTCAE. The change in severity from baseline to 3 months was calculated and it ranged from -3 to 3. The severity was measured on a 0-3 (0=None, 3=Severe) scale with a higher value representing a worse outcome and a lower value representing a better outcome. This was done separately for pain, fatigue, nausea, and anxiety.

Analysis population: Due to missing patient reported outcomes the overall number of participants analyzed differs from patients that completed the study.

Groups in this outcome

Arm I (Acupuncture, Acupressure, Cryotherapy)

Patients undergo acupuncture during chemotherapy infusion on day 1 and fluorouracil pump disconnect on day 3 of each biweekly chemotherapy infusion over 12 weeks. Patients also undergo self-administered acupressure over 11 minutes daily for 12 weeks and undergo standard of care oral cryotherapy. Acupuncture Therapy: Undergo acupuncture Acupressure Therapy: Undergo acupressure Oral Cryotherapy: Undergo oral cryotherapy Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies

Arm II (Cryotherapy)

Patients undergo standard of care oral cryotherapy. Oral Cryotherapy: Undergo oral cryotherapy Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I (Acupuncture, Acupressure, Cryotherapy)20
Arm II (Cryotherapy)27

Reported measurements

Pain

Analysis denominator · Participants

GroupSource count
Arm I (Acupuncture, Acupressure, Cryotherapy)19
Arm II (Cryotherapy)27
Values in units on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Arm I (Acupuncture, Acupressure, Cryotherapy)-0.31.2Not reportedNot reportedNot reported
Arm II (Cryotherapy)-0.31.1Not reportedNot reportedNot reported
Fatigue

Analysis denominator · Participants

GroupSource count
Arm I (Acupuncture, Acupressure, Cryotherapy)20
Arm II (Cryotherapy)27
Values in units on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Arm I (Acupuncture, Acupressure, Cryotherapy)-0.10.9Not reportedNot reportedNot reported
Arm II (Cryotherapy)0.41.2Not reportedNot reportedNot reported
Nausea

Analysis denominator · Participants

GroupSource count
Arm I (Acupuncture, Acupressure, Cryotherapy)19
Arm II (Cryotherapy)27
Values in units on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Arm I (Acupuncture, Acupressure, Cryotherapy)-0.30.7Not reportedNot reportedNot reported
Arm II (Cryotherapy)0.31.0Not reportedNot reportedNot reported
Anxiety

Analysis denominator · Participants

GroupSource count
Arm I (Acupuncture, Acupressure, Cryotherapy)19
Arm II (Cryotherapy)27
Values in units on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Arm I (Acupuncture, Acupressure, Cryotherapy)-0.11.0Not reportedNot reportedNot reported
Arm II (Cryotherapy)-0.10.9Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.2
        value
        -0.3
      2. group Id
        OG001
        spread
        1.1
        value
        -0.3
    denoms
    1. counts
      1. group Id
        OG000
        value
        19
      2. group Id
        OG001
        value
        27
      units
      Participants
    title
    Pain
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        0.9
        value
        -0.1
      2. group Id
        OG001
        spread
        1.2
        value
        0.4
    denoms
    1. counts
      1. group Id
        OG000
        value
        20
      2. group Id
        OG001
        value
        27
      units
      Participants
    title
    Fatigue
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        0.7
        value
        -0.3
      2. group Id
        OG001
        spread
        1.0
        value
        0.3
    denoms
    1. counts
      1. group Id
        OG000
        value
        19
      2. group Id
        OG001
        value
        27
      units
      Participants
    title
    Nausea
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.0
        value
        -0.1
      2. group Id
        OG001
        spread
        0.9
        value
        -0.1
    denoms
    1. counts
      1. group Id
        OG000
        value
        19
      2. group Id
        OG001
        value
        27
      units
      Participants
    title
    Anxiety
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    2. group Id
      OG001
      value
      27
    units
    Participants
description
Measured by patient-reported National Cancer Institute \[NCI\] Patient Reported Outcomes \[PRO\]-CTCAE. The change in severity from baseline to 3 months was calculated and it ranged from -3 to 3. The severity was measured on a 0-3 (0=None, 3=Severe) scale with a higher value representing a worse outcome and a lower value representing a better outcome. This was done separately for pain, fatigue, nausea, and anxiety.
dispersion Type
Standard Deviation
groups
  1. description
    Patients undergo acupuncture during chemotherapy infusion on day 1 and fluorouracil pump disconnect on day 3 of each biweekly chemotherapy infusion over 12 weeks. Patients also undergo self-administered acupressure over 11 minutes daily for 12 weeks and undergo standard of care oral cryotherapy. Acupuncture Therapy: Undergo acupuncture Acupressure Therapy: Undergo acupressure Oral Cryotherapy: Undergo oral cryotherapy Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies
    id
    OG000
    title
    Arm I (Acupuncture, Acupressure, Cryotherapy)
  2. description
    Patients undergo standard of care oral cryotherapy. Oral Cryotherapy: Undergo oral cryotherapy Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies
    id
    OG001
    title
    Arm II (Cryotherapy)
param Type
MEAN
population Description
Due to missing patient reported outcomes the overall number of participants analyzed differs from patients that completed the study.
reporting Status
POSTED
time Frame
3 months
title
Change in Severity of Pain, Fatigue, Nausea, and Anxiety From Baseline to 3 Months
type
SECONDARY
unit Of Measure
units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice